Natrelle® Enhances Healthcare Access Through Vizient Partnership
Natrelle® Partners with Vizient for Enhanced Healthcare Solutions
This exciting new agreement allows Vizient clients to enjoy improved access to Natrelle®, offering a broad selection of breast implant options available in the market. With over 300 diverse implant choices, Natrelle® stands as a premier option for healthcare providers.
Streamlined Access and Benefits for Healthcare Providers
The collaboration between Natrelle® and Vizient connects the brand to a wide network of healthcare institutions. This includes academic medical centers, community hospitals, integrated delivery networks, and many non-acute care providers, effectively reaching over half of healthcare organizations across the United States.
Through this partnership, Vizient clients will benefit from competitive pricing, a simplified procurement process, and increased operational efficiency. Additionally, healthcare providers will receive direct support from the seasoned sales and technical teams of Natrelle®.
Commitment to Patient Care and Support
Glen Curran, Senior Vice President of Allergan Aesthetics, expressed enthusiasm about the partnership: "This agreement with Vizient reflects our commitment to support women during their breast reconstruction journeys. We aim to equip providers with the necessary tools to ensure exceptional care delivery. We are proud to offer Natrelle® to Vizient's clients and support patient-centered outcomes."
Legacy of Excellence in Breast Implants
Natrelle® is recognized for its 50-year legacy of innovation in breast implant technology. It is currently the preferred choice among plastic surgeons. For those considering breast augmentation or reconstruction, it is essential to select a trusted brand like Natrelle®, known for its commitment to quality and safety.
Understanding Breast Implant Safety Information
However, it is crucial to note that breast implants are not lifetime devices; the longer they remain in the body, the higher the likelihood of developing complications, some potentially requiring additional surgeries. Moreover, patients should be aware of breast implant–associated risks, including the possibility of developing anaplastic large cell lymphoma (BIA-ALCL), particularly among those with textured implants.
Patients often report systemic symptoms post-implantation, such as muscle pain, fatigue, and autoimmune disorders, though individual risks may vary. Consulting with a healthcare professional prior to surgery is essential for assessing personal risks and understanding the implications of breast implants.
Considerations Before Receiving Breast Implants
Who is a candidate for breast implants? Natrelle® breast implants are approved for women aged at least 22 years for silicone implants and 18 years for saline implants, specifically for breast augmentation and reconstruction post-cancer or trauma.
On the other hand, certain individuals should avoid breast implant surgery, especially those with active infections, existing breast cancer, or those who are pregnant or nursing. Open dialogue with healthcare providers regarding existing health conditions, especially autoimmune disorders, is imperative.
Benefits and Implications of Choosing Natrelle®
Choosing Natrelle® breast implants signifies opting for a brand that focuses on scientific integrity and aesthetic excellence. As part of Allergan Aesthetics, Natrelle® benefits from extensive research and clinical studies, ensuring that patients and surgeons alike can find satisfactory options for their individual needs and outcomes.
Routine screenings and follow-ups are essential for ensuring that breast implants remain safe and functional. Patients are encouraged to maintain regular communication with their healthcare provider to monitor any potential complications or side effects following implantation.
Additional Information About Allergan Aesthetics
Allergan Aesthetics is dedicated to research that empowers confidence through innovative aesthetics solutions. With a portfolio encompassing various products from facial injectables to body contouring, the company continues to support the beauty and wellness industry in providing top-notch services to clients.
Frequently Asked Questions
What is the significance of the Natrelle® and Vizient partnership?
This partnership enhances access to a wide range of breast implant options for healthcare providers, ensuring competitive pricing and improved support.
How does Natrelle® ensure quality in its products?
Natrelle® implants are backed by over 600 studies and a 50-year legacy of research, ensuring patient and surgeon satisfaction.
What are potential risks associated with breast implants?
Risks include complications that may arise over time, including BIA-ALCL in textured implants and systemic symptoms that can affect some patients.
Who is eligible to receive Natrelle® breast implants?
Women over 18 for saline-filled and over 22 for silicone-filled implants can receive Natrelle® implants, subject to health conditions.
What should patients consider post-implantation?
Patients need to engage in routine screenings, monitor for any unusual symptoms, and maintain communication with their healthcare provider.
About The Author
Contact Hannah Lewis privately here. Or send an email with ATTN: Hannah Lewis as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.